NDC 70954-201 – Digoxin
Digoxin .125 mg/1 · Tablet · Oral
Product NDC70954-201
Product details
- Brand name
- Digoxin
- Generic name
- Digoxin
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA215307
- Marketed since
- November 22, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cardiac Glycoside
Active ingredients
- Digoxin .125 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70954-201-10 | 100 TABLET in 1 BOTTLE (70954-201-10) | Nov 22, 2021 |
| 70954-201-20 | 1000 TABLET in 1 BOTTLE (70954-201-20) | Nov 22, 2021 |
Recalls mentioning this NDC
- D-0443-2024 Apr 24, 2024 · Class III
Failed Impurities/Degradation Specifications - D-0389-2024 Mar 27, 2024 · Class III
Cross Contamination with Other Products:(mycophenolate mofetil).
Other Digoxin products
- 50090-5642 Digoxin 125 ug/1 · Tablet · A-S Medication Solutions
- 50090-6588 Digoxin 250 ug/1 · Tablet · A-S Medication Solutions
- 50090-7865 Digoxin .25 mg/1 · Tablet · A-S Medication Solutions
- 50090-5862 Digoxin 250 ug/1 · Tablet · A-S Medication Solutions
- 50090-6708 Digoxin .125 mg/1 · Tablet · A-S Medication Solutions
- 60687-858 Digoxin .125 mg/1 · Tablet · American Health Packaging
- 60687-869 Digoxin .25 mg/1 · Tablet · American Health Packaging
- 69238-1992 Digoxin 250 ug/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 69238-1991 Digoxin 125 ug/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 0115-9811 Digoxin 125 ug/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 0115-9822 Digoxin 250 ug/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 70954-200 Digoxin .0625 mg/1 · Tablet · ANI Pharmaceuticals, Inc.